Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...

SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...

A new dry simulator revolutionizes training for complex endoscopic cancer resection.A research team at Tohoku University, in ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

Please provide your email address to receive an email when new articles are posted on . In 2020, the global lifetime risk for developing and dying from gastrointestinal cancers was 8.2% and 6.17%.